Literature DB >> 221668

Cell-free synthesis of mouse mammary tumor virus Pr77 from virion and intracellular mRNA.

H H Dahl, C Dickson.   

Abstract

Mouse mammary tumor virus (MuMTV) was purified from two cell lines (GR and Mm5MT/c1), and the genomic RNA was isolated and translated in vitro in cell-free systems derived from mouse L cells and rabbit reticulocytes. The major translation product in both systems was a protein with the molecular weight 77,000. Several other products were also detected, among them a 110,000-dalton and in minor amounts a 160,000-dalton protein. All three polypeptides were specifically immunoprecipitated by antiserum raised against the major core protein of MuMTV (p27), but they were not precipitated by antiserum against the virion glycoprotein gp52. Analysis of the in vitro products by tryptic peptide mapping established their relationship to the virion non-glycosylated structural proteins. The 77,000-dalton polypeptide was found to be similar, if not identical, to an analogous precursor isolated from MuMTV-producing cells. Peptide mapping of the 110,000-dalton protein shows that it contains all of the methionine-labeled peptides found in the 77,000-dalton protein plus some additional peptides. We conclude that the products synthesized in vitro from the genomic MuMTV RNA are related to the non-glycosylated virion structural proteins. Polyadenylic acid-containing RNA from MuMTV-producing cells also directed the synthesis of the 77,000-dalton polypeptide in the L-cell system. If this RNA preparation was first fractionated by sucrose gradient centrifugation the 77,000-dalton protein appeared to be synthesized from mRNA with a sedimentation coefficient between 25 and 35S.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221668      PMCID: PMC353273     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Cell-free synthesis of the precursor polypeptide for avian myeloblastosis virus DNA polymerase.

Authors:  B M Paterson; D J Marciani; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

2.  The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukosis viruses.

Authors:  S R Weiss; H E Varmus; J M Bishop
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

3.  Cell-free synthesis of simian virus 40 T-antigens.

Authors:  E Paucha; R Harvey; A E Smith
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

4.  The structure of the mouse mammary tumor virus: isolation and characterization of the core.

Authors:  Y A Teramoto; R D Cardiff; J K Lund
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

5.  Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

6.  A joint produce of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase.

Authors:  H Oppermann; J M Bishop; H E Varmus; L Levintow
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

7.  Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA.

Authors:  E C Murphy; J J Kopchick; K F Watson; R B Arlinghaus
Journal:  Cell       Date:  1978-02       Impact factor: 41.582

8.  Electron microscopy of tumor cells and tumor viruses; a review.

Authors:  W BERNHARD
Journal:  Cancer Res       Date:  1958-06       Impact factor: 12.701

9.  Mapping oligonucleotides of Rous sarcoma virus RNA that segregate with polymerase and group-specific antigen markers in recombinants.

Authors:  L Wang; D Galehouse; P Mellon; P Duesberg; W S Mason; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Polyproteins related to the major core protein of mouse mammary tumor virus.

Authors:  C Dickson; M Atterwill
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

View more
  14 in total

1.  Protein-coding potential of mouse mammary tumor virus genome RNA as examined by in vitro translation.

Authors:  C Dickson; G Peters
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

2.  Synthesis of murine mammary tumor viral proteins in vitro.

Authors:  G C Sen; J Racevskis; N H Sarkar
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

3.  Subcellular location of an abundant substrate (p36) for tyrosine-specific protein kinases.

Authors:  S Courtneidge; R Ralston; K Alitalo; J M Bishop
Journal:  Mol Cell Biol       Date:  1983-03       Impact factor: 4.272

4.  Structure and processing of the mouse mammary tumor virus glycoprotein precursor pr73env.

Authors:  C Dickson; M Atterwill
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

5.  Analysis of secondary modifications of mouse mammary tumor virus proteins by two-dimensional gel electrophoresis.

Authors:  R Nusse; H Janssen; L de Vries; R Michalides
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

6.  Translation of vaccinia virus and cellular mRNA in cell-free systems prepared from uninfected and vaccinia virus infected L929 cells.

Authors:  P W Tas
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product.

Authors:  L O Arthur; T D Copeland; S Oroszlan; G Schochetman
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

8.  Coronavirus JHM: cell-free synthesis of structural protein p60.

Authors:  S G Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

9.  Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA.

Authors:  A J van Ooyen; R J Michalides; R Nusse
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  Dexamethasone induction of the intracellular RNAs of mouse mammary tumor virus.

Authors:  D L Robertson; H E Varmus
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.